The Artery Pill
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 50% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
2 Softgel(s)
Serving Size
30
Servings
Fat/Fatty Acid
Product Type
50%
Evidence Coverage
Supplement Facts — Evidence Check
Calories
20 Calorie(s)
Total Fat
2 Gram(s)
(3% DV)
Cholesterol
5 mg
(2% DV)
25 mcg
(125% DV)
✅ 1.7× RDA — within safe limits
📚 604 studies (Tier A: 16, B: 251)
180 mcg
(150% DV)
✅ 1.5× RDA — within safe limits
📚 273 studies (Tier A: 9, B: 175)
1100 mg
📊 Market median: 750.0mg (447 products)
📚 388 studies (Tier A: 18, B: 204)
Other Ingredients
highly refined and concentrated Omega-3 Fish Oil
Capsule Shell
MenaQ7
Proprietary LemonLock Freshness System
Cholecalciferol
Label Claims — Verification
❓
Nutrient
❓
All Other
❓
Structure/Function
All Other (100% of products)
Structure/Function (84% of products)
Nutrient (73% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Suggested Use: Adults take 2 soft gels daily with a meal. For daily use.
⚠️ Warnings & Precautions
Contains fish: (anchovy, sardine, mackerel) and soy.
Warning: This product contains vitamin K, which interferes with anticoagulants such as coumadin and warfarin. Do not take if taking anticoagulant medications.
🧪 Formulation Notes
Arterial support formula with omega-3 fish oil, vitamin K2 & vitamin D
Supports cardio health Helps maintain healthy arteries
1 gram EPA/DHA + vitamin K2
Additional Information
Intelligent nutritional solutions
Premium grade supplements Since 1993
Product Details
DSLD Entry Date
2021-03-25
Product Type
Fat/Fatty Acid
Form
Softgel Capsule
Brand
Purity Products
DSLD ID
244180
Data Updated
2026-04-11
Research Evidence
332
Research Sources
59
Avg Quality Score
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
A
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Compare Similar Products
Vitamin K-2
GNC Preventive Nutrition
100
Vitamin K-2
NewtonEverett
100
Low-Dose Vitamin K2 45 mcg
Life Extension
100
Natural Vitamin K-2 Bioactive Form
Vitamin World
100
Vitamin K2 50 mcg
Vitacost
100